2021
DOI: 10.2174/1389201021666201104144509
|View full text |Cite
|
Sign up to set email alerts
|

Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19

Abstract: Background: The COVID-19 pandemic had infected more than 3.5M people around the world and more than 250K people died in 187 countries by May 2020. The causal agent of this disease is a coronavirus whose onset of symptoms to death range from 6 to 41 days with a median of 14 days. This period is dependent on several factors such as the presence of comorbidities, age and the efficiency of the innate or adaptive immune responses. The effectors mechanisms of both types of immune responses depend on the pathogen inv… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles